Patient P-03296

Synthetic patientONX-7 · Day 122 · 55–64 · M · baseline S16Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Favorable

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Improving

Discontinuation risk

14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S16

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-8
Nutritional resilience+6
Inflammatory activity-4
Treatment adherence-3
Toxicity-3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

5.9/10

improving · +0.6 vs previous 14 d

Stress level

Daily log

3.7/10

improving · -0.3 vs previous 14 d

Pessimism score

Daily log

3.3/10

improving · -0.4 vs previous 14 d

Sleep quality

Wearable

34.2/100

improving · +8.4 vs previous 14 d

Libido

Daily log

4.4/10

improving · +0.2 vs previous 14 d

HRV

Wearable

37.9 ms

improving · +3.1 vs previous 14 d

Toxicity

Blood

20.9/100

stable · -0.1 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 74 from the failing basin, 19 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +8.4
Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -4.8 next day

Main detractors to watch

IL6 high-expression variant
hidden · steering -7.3
Alcohol
perturbation · steering -4
Poor-sleep week
perturbation · steering -3
Dietary drift
perturbation · steering -2.6
Alcohol
detractor · GI +2.4 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.8supporter · 95%
Alcohol
+2.4detractor · 59%
Histamine load
+1.7no signal · 33%
Caffeine
+1.7no signal · 42%
Lactose
+1.5no signal · 31%
Dietary fat load
-1.3no signal · 25%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↑45
- WearableResting HR 77 bpm
- Wearable3,953 steps/day
Inflammatory signalling ↓40
- DNAIL6 -174 variant raises baseline inflammatory tone
- WearableHRV 38 ms, trending down

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Intermediate metabolizer
Expected exposure

Microbiome

Shannon diversity 3.6 · butyrate capacity 50/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 36 ms
Sleep: 5.8 h
Steps: 3,967
Resting HR: 76 bpm

Daily log: GI score 17, nutritional resilience 69, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03105	47%	S12	AD-05	no change	60
P-03482	47%	S05	AD-05	no change	67
P-03204	40%	S16	AD-05	improved	48
P-03111	36%	S07	AD-05	no change	48
P-03187	34%	S12	AD-05	no change	80
P-03351	34%	S07	AD-05	no change	51
P-03380	33%	S16	AD-05	improved	34
P-03424	33%	S12	AD-05	improved	41
P-03369	32%	S18	AD-05	no change	37
P-03441	31%	S19	AD-05	improved	37
P-03034	29%	S14	AD-05	no change	30
P-03122	29%	S13	AD-05	no change	40